未登录

E

Elizabeth T. Masters

Pfizer

H指数:19

被引数:1,390

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study

ADVANCES IN THERAPY

IF4

2020-05-2914

PREAI

Real-World Use and Outcomes of ALK-Positive Crizotinib-Treated Metastatic NSCLC in US Community Oncology Practices: A Retrospective Observational Study

美国社区肿瘤学实践中ALK阳性克唑替尼治疗转移性NSCLC的真实世界使用和结果: 一项回顾性观察研究

JOURNAL OF CLINICAL MEDICINE

IF2.9

2018-05-2912

OAAI

Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2017-10-175

OAAI

Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2017-06-0145

OAAI

A fully automated algorithm for identifying patients with problem prescription opioid use using electronic health record data

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2017-02-012

PREAI

NATURAL LANGUAGE PROCESSING-IDENTIFIED PROBLEM OPIOID USE AND ITS ASSOCIATED HEALTH CARE COSTS

VALUE IN HEALTH

IF6

2016-05-011

OAAI

A model to quantify potential medical events avoided and cost savings from abuse deterrent opioids

JOURNAL OF PAIN

IF4

2016-04-011

PREAI

Identification of high healthcare resource utilizers among patients with fibromyalgia using electronic health records

JOURNAL OF PAIN

IF4

2016-04-011

OAAI

Using natural language processing to identify problem usage of prescription opioids

INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS

IF4.1

2015-12-0196

PREAI

The prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notes

IF5.5

2015-07-0156

PREAI

MULTISITE PROSPECTIVE OBSERVATIONAL STUDY OF FIBROMYALGIA PATIENTS IN THE US

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2015-06-010

PREAI

COST OF TAMPERING IN ABUSE OF PRESCRIPTION OPIOIDS

VALUE IN HEALTH

IF6

2015-05-010

OAAI

DRIVERS OF HEALTHCARE RESOURCE UTILIZATION AND FACTORS ASSOCIATED WITH INCREASED RESOURCE USE IN PATIENTS WITH FIBROMYALGIA: AN EVALUATION USING ELECTRONIC MEDICAL RECORDS

VALUE IN HEALTH

IF6

2015-05-011

OAAI

PREVALENCE AND ECONOMIC BURDEN OF PRESCRIPTION OPIOID MISUSE AND ABUSE SYSTEMATIC REVIEW

VALUE IN HEALTH

IF6

2015-05-011

OAAI

Automated Prediction of Risk for Problem Opioid Use in a Primary Care Setting

JOURNAL OF PAIN

IF4

2015-04-0161

OAAI

Extracting unstructured data from electronic health records (EHR) to enhance opioid risk assessment in patients with chronic non-cancer pain

JOURNAL OF PAIN

IF4

2015-04-010

PREAI

Transitions among chronic pain and fibromyalgia patients: results from a two-year observational fibromyalgia study in the United States

JOURNAL OF PAIN

IF4

2015-04-010

PREAI

Economic burden of chronic widespread pain and fibromyalgia in the US

JOURNAL OF PAIN

IF4

2014-04-010

OAAI

The prevalence and characteristics of patients with indicators of opioid abuse within an integrated group practice

JOURNAL OF PAIN

IF4

2014-04-011

PREAI

Estimating Individual-Level Exposure to Airborne Polycyclic Aromatic Hydrocarbons throughout the Gestational Period Based on Personal, Indoor, and Outdoor Monitoring

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

2008-11-0178

OAAI